DV
Dividend Vision

ANIK — Anika Therapeutics Inc

Anika Therapeutics Inc (ANIK)

Total return is 514.3% over the past 33.3 years, 2562.5 points behind SPY at 3076.8%. Its deepest 1-year drawdown was 22.6%.

ANIK is an equity fund that holds Anika Therapeutics Inc, a single-stock fund focused on a company operating in the therapeutic/pharmaceutical sector. The fund does not currently pay distributions, resulting in a N/A distribution rate, and operates with an unknown expense ratio. This fund structure appeals primarily to investors seeking direct exposure to Anika Therapeutics' stock performance rather than those prioritizing dividend income.

ANIK key facts

Asset type
Stock
Asset class
Equity
Inception date
05/03/1993
Last close
$21.50
Market cap
$202,910,768
Average volume
124986.0
Beta
0.227
Payout ratio
0.0
Forward P/E
37.1747
EPS
$-0.79